These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15790024)

  • 1. [A new screening test for colorectal cancer?].
    Nau JY
    Rev Med Suisse; 2005 Feb; 1(7):522. PubMed ID: 15790024
    [No Abstract]   [Full Text] [Related]  

  • 2. [Colorectal cancer screening: facts and questions].
    Faivre J; Dancourt V
    Gastroenterol Clin Biol; 2002 May; 26(5 Suppl):B86-93. PubMed ID: 12068275
    [No Abstract]   [Full Text] [Related]  

  • 3. Does fecal occult blood test have a place for colorectal cancer screening in China in 2006?
    Sung J
    Am J Gastroenterol; 2006 Feb; 101(2):213-5. PubMed ID: 16454819
    [No Abstract]   [Full Text] [Related]  

  • 4. [Detection and mass - screening programs of colorectal cancer].
    Gornet JM
    Pathol Biol (Paris); 2004 Apr; 52(3):115-6. PubMed ID: 15063927
    [No Abstract]   [Full Text] [Related]  

  • 5. The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective.
    Bond JH
    Am J Gastroenterol; 2006 Feb; 101(2):219-21. PubMed ID: 16454821
    [No Abstract]   [Full Text] [Related]  

  • 6. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
    Jansen JB; van Rossum LG; Laheij RJ
    Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Faecal occult blood test and mass screening for colorectal cancer].
    Hiwatashi N; Shimada T
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():201-6. PubMed ID: 14574882
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of fecal occult-blood screening on the incidence of colorectal cancer.
    Allison JE
    N Engl J Med; 2001 Mar; 344(13):1022; author reply 1023. PubMed ID: 11280326
    [No Abstract]   [Full Text] [Related]  

  • 9. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
    Malila N; Hakama M; Pukkala E
    Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From screening criteria to colorectal cancer screening: what can New Zealand learn from other countries?
    Shaw C; Cunningham R; Sarfati D
    N Z Med J; 2008 Aug; 121(1279):84-95. PubMed ID: 18709051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.
    Saito H
    J Med Screen; 2006; 13 Suppl 1():S6-7. PubMed ID: 17227634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening for colorectal cancer: what is the most effective strategy?].
    Merzenich H; Giersiepen K; Kieschke J; Zeeb H
    Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon cancer screening: the good, the bad, and the ugly.
    Roy HK; Backman V; Goldberg MJ
    Arch Intern Med; 2006 Nov; 166(20):2177-9. PubMed ID: 17101934
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective comparative evaluation of an office-based rapid immunological test with a Guaiac-based fecal occult blood test for colorectal cancer screening in general population with average-risk.
    Shastri YM; Loitsch S; Nowak R; Povse N; Stein J
    Clin Lab; 2008; 54(9-10):385-7. PubMed ID: 19097496
    [No Abstract]   [Full Text] [Related]  

  • 16. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer (Br J Surg 2009; 96: 533-540).
    Nash GF
    Br J Surg; 2009 Aug; 96(8):956-7; author reply 957. PubMed ID: 19591144
    [No Abstract]   [Full Text] [Related]  

  • 17. The feasibility of FOBT tests in colorectal cancer screening.
    Pojoga C
    Rom J Gastroenterol; 2005 Dec; 14(4):432. PubMed ID: 16400364
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of population-based faecal occult blood test screening upon emergency colorectal cancer admissions in Coventry and north Warwickshire.
    Logan RF
    Gut; 2008 Sep; 57(9):1333; author reply 1333-4. PubMed ID: 18719146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.